By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Replikins 

38 the Fenway

Boston  Massachusetts  02215  U.S.A.
Phone: 617-536-0220 Fax: 617-536-0657


SEARCH JOBS


Industry
Biotechnology






Company News
Anti-Microcephaly Vaccine-Blocker Candidate: Based On Zika Virus Gene Replikins In Human Fetal Microcephaly 8/3/2016 8:12:11 AM
Zika Virus Gene Replikins: Significant Mutations Detected 7/12/2016 6:47:11 AM
Replikins Release: First Response To Zika Replikins Vaccine Candidates Reported 5/6/2016 6:35:21 AM
Zika, Dengue And Japanese-Encephalitis Trivalent Synthetic Replikins Vaccine-Blocker Candidate Being Tested In Animals, With July 2016 Goal To Begin Human Trials 4/13/2016 6:42:12 AM
MERS And Ebola Replikins Synthetic Vaccine-Blocker Candidates Presented At Meeting Of Int'l Society For Neglected Tropical Diseases At Wellcome Trust May 20th 6/5/2015 6:31:06 AM
Replikins Release; New Genomic Analysis Shows H5N1 (Bird Flu) Replikin Count Highest Among Five Influenza Strains 10/10/2013 9:22:43 AM
Replikins Release: Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria 3/14/2013 10:19:51 AM
Replikins Release: Recent Outbreak of Hand-Foot-Mouth Disease in 2.2 Million Children (WHO) Preceded and Predicted by Increase in the HFMD Genomic Replikin® Count 2/20/2013 9:51:24 AM
New Shared Synthetic Replikins Cancer Vaccines 1/22/2013 10:12:12 AM
Replikins Release: Replikin Count of Influenza H3N2 Replikin Lethality Gene in the U.S. Approaches That of 1968 H3N2 Pandemic 1/17/2013 9:29:09 AM
12
//-->